{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:51Z","timestamp":1786119291747,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1097\/mbc.0b013e3282f2b5fd","type":"journal-article","created":{"date-parts":[[2008,3,27]],"date-time":"2008-03-27T03:06:54Z","timestamp":1206587214000},"page":"208-211","source":"Crossref","is-referenced-by-count":24,"title":["The use of rituximab as an adjuvant for immune tolerance therapy in a hemophilia B boy with inhibitor and anaphylaxis to factor IX concentrate"],"prefix":"10.1097","volume":"19","author":[{"given":"Ampaiwan","family":"Chuansumrit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingwan","family":"Moonsup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nongnuch","family":"Sirachainan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwat","family":"Benjaponpitak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atchara","family":"Suebsangad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pakawan","family":"Wongwerawattanakoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210203","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM199302183280701","article-title":"Recombinant FVIII in previously untreated subjects with hemophilia A: a 3.5 year observational study of safety, efficacy and inhibitor development","volume":"328","author":"Lusher","year":"1993","journal-title":"N Engl J Med"},{"key":"R2-5-20210203","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/0140-6736(92)90874-3","article-title":"Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs","volume":"339","author":"Ehrenforth","year":"1992","journal-title":"Lancet"},{"issue":"Suppl 1","key":"R3-5-20210203","first-page":"47","article-title":"Factor IX inhibitors in hemophilia B patients: their incidence and prospects for development with high purity factor IX products","volume":"2","author":"Briet","year":"1991","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"Suppl 1","key":"R4-5-20210203","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000204029","article-title":"Gene mutations and inhibitor formation in patients with haemophilia B","volume":"94","author":"Ljung","year":"1995","journal-title":"Acta Haematol"},{"key":"R5-5-20210203","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/nar\/21.13.3075","article-title":"Haemophilia B: database of point mutations and short additions and deletions","volume":"21","author":"Giannelli","year":"1993","journal-title":"Nucleic Acids Res"},{"key":"R6-5-20210203","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2516.2006.01185.x","article-title":"Rituximab in the treatment of high responding inhibitors in severe hemophilia A","volume":"12","author":"Moschovi","year":"2006","journal-title":"Haemophilia"},{"key":"R7-5-20210203","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1365-2516.2006.01407.x","article-title":"Rituximab as an adjuvant therapy to immune tolerance in a hemophilia A boy with high inhibitor titer","volume":"13","author":"Chuansumrit","year":"2007","journal-title":"Haemophilia"},{"key":"R8-5-20210203","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2141.2004.04916.x","article-title":"Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with haemophilia","volume":"125","author":"Mathia","year":"2004","journal-title":"Br J Haematol"},{"key":"R9-5-20210203","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0091-6749(98)70061-2","article-title":"Ig E mediated allergy and desensitization to factor IX in hemophilia B","volume":"102","author":"Dioun","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"R10-5-20210203","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0049-3848(96)00136-3","article-title":"Measurement of antifactor IX Ig G subclasses in haemophilia B patients who developed inhibitors with episodes of allergic reactions to factor IX concentrates","volume":"83","author":"Sawamoto","year":"1996","journal-title":"Thromb Res"},{"key":"R11-5-20210203","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1365-2516.2001.0538c.x","article-title":"Induction of immune tolerance and suppression of anaphylaxis in a child with haemophilia B by simple plasmapheresis and antigen exposure: progress report","volume":"7","author":"Barnes","year":"2001","journal-title":"Haemophilia"},{"key":"R12-5-20210203","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-2516.2003.00772.x","article-title":"Management of haemophilia B inhibitor patients with anaphylactic reaction to FIX concentrate","volume":"9","author":"Shibata","year":"2003","journal-title":"Haemophilia"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001721-200804000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:57:25Z","timestamp":1786039045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200804000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e3282f2b5fd","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}